Male infertility. The use of antioxidants and zinc in the treatment of fertility disorders and inflammatory diseases of male genitalia (clinical lecture)

Cover Page

Cite item

Full Text

Abstract

This clinical lecture paper examines the current demographic problems of Russia, the dynamics of fertility and mortality, social aspects. The data on male infertility, its causes and consequences. Particular attention is paid to the health of the younger generation, its demographic prospects, as well as modern concepts of marriage and the family in terms of male infertility, complications during fertilization, pregnancy and childbirth is presented. In considering the problems associated with infections, sexually transmitted infections, and nonspecific inflammation male genitalia focuses on not only their frequency but also a significant role in the development of disorders of male infertility and infertile marriages. When considering the pathogenesis of male infertility focuses on the problems of oxidative stress and micronutrient deficiencies, possibilities of modern complex therapy with zinc, antioxidants and its prospects.

About the authors

V. V Borisov

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Email: vvb56@yandex.ru
д-р мед. наук, проф. каф. нефрологии и гемодиализа ИПО ГБОУ ВПО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

References

  1. Федеральная служба государственной статистики. Официальный сайт. http://www.gks.ru/
  2. ВОЗ - Всемирная организация здравоохранения. Официальный сайт. http://www.who.int/ru/
  3. Борисов В.В. Антиоксидативная терапия мужских сексуальных и репродуктивных расстройств. Consilium Medicum. 2014; 16 (7): 41.
  4. UroWeb.ru. Урологический информационный портал, 2015.
  5. Шадеркина В.А., Болотова Е.В. Проблема здоровья мальчиков в современной России. UroWeb.ru. Урологический информационный портал. 2015.
  6. Lotti F, Corona G, Vitale P et al. Current smoking is associated with lower seminal vesicles and ejaculate volume, despite higher testosterone levels, in male subjects of infertile couples. Hum Reprod 2015; 30: 590-602.
  7. Br Med J Open, 2015.
  8. Тюзиков И.А., Калинченко С.Ю., Ворслов Л.О., Тишова Ю.А. Бесплодие: определение, эпидемиология, причины, классификация, критерии прогноза. Эксперим. и клин. урология. 2014; 2.
  9. Panda B, Dash C, Padhy R.N, Routray P. Effect of age and abstinence on semen quality: A retrospective study in a teaching hospital Priyadarsini Sunanda. Asian Pacific J Reprod 2014.
  10. Виноградов И.В., Страшнова А.Л., Афанасьева Л.М. и др. Применение различных методов оценки сперматозоидов в клинической практике. Материалы XI Конгресса «Мужское здоровье». М., 2010; с. 195-7.
  11. Божедомов В.А. Мужское бесплодие. М., 2009.
  12. Zini A, Al-Hathal N. Antioxidant therapy in male infertility: fact or fiction? Asian J Androl 2011; 13: 374
  13. Zini A, San Gabriel M, Baazeem A. Antioxidants and sperm DNA damage: a clinical perspective. J Assist Reprod Genet 2009; 26: 427-32.
  14. Aitken R.J, de Iuliis G.N, Finnie J.M et al. Analysis of the relationships between oxidative stress, DNA damage and sperm vitality in a patient population: development of diagnostic criteria. Hum Reprod 2010; 25: 2415-26.
  15. Fraga C.G, Motchnik P.A, Shigenaga M.K et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci USA 1991; 88: 11003-6.
  16. Iwasaki A, Gagnon C. Formation of reactive oxygen species in spermatozoa of infertile patients. Fertil Steril 1992; 57: 409-16.
  17. Zini A, Sigman M. Are tests of sperm DNA damage clinically useful? Pros and cons.J Androl 2009; 30: 219-29.
  18. Agarwal A, Nallella K.P, Allamaneni S.S, Said T.M. Role of antioxidants in treatment of male infertility: an overview of the literature. Reprod Biomed Online 2004; 8: 616-27.
  19. Aitken R.J, Paterson M, Fisher H et al. Redox regulation of tyrosine phosphorylation in human spermatozoa and its role in the control of human sperm function. J Cell Sci 1995; 108 (Pt. 5): 2017-25.
  20. Griveau J.F, Le Lannou D. Reactive oxygen species and human spermatozoa: physiology and pathology. Int J Androl 1997; 20: 61-9.
  21. De Lamirande E, Jiang H, Zini A et al. Reactive oxygen species and sperm physiology. Rev Reprod 1997; 2: 48-54.
  22. Aitken R.J, Clarkson J.S. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. J Reprod Fertil 1987; 81: 459-69.
  23. De Lamirande E, Gagnon C. Reactive oxygen species and human spermatozoa. I. Effects on the motility of intact spermatozoa and on sperm axonemes. J Androl 1992; 13: 368-78.
  24. Zini A, Garrels K, Phang D. Antioxidant activity in the semen of fertile and infertile men. Urology 2000; 55: 922-6.
  25. Alvarez J.G, Touchstone J.C, Blasco L, Storey B.T. Spontaneous lipid peroxidation and production of hydrogen peroxide and superoxide in human spermatozoa. Superoxide dismutase as major enzyme protectant against oxygen toxicity. J Androl 1987; 8: 338-48.
  26. Twigg J, Fulton N, Gomez E et al. Analysis of the impact of intracellular reactive oxygen species generation on the structural and functional integrity of human spermatozoa: lipid peroxidation, DNA fragmentation and effectiveness of antioxidants. Hum Reprod 1998; 13: 1429-36.
  27. Chabory E, Damon C, Lenoir A et al. Epididymis seleno - independent glutathione peroxidase 5 maintains sperm DNA integrity in mice. J Clin Invest 2009; 119: 2074-85.
  28. Weir C.P, Robaire B. Spermatozoa have decreased antioxidant enzymatic capacity and increased reactive oxygen species production during aging in the Brown Norway rat. J Androl 2007; 28: 229-40.
  29. Zini A, de Lamirande E, Gagnon C. Low levels of nitric oxide promote human sperm capacitation in vitro. J Androl 1995; 16: 424-31.
  30. Smith R, Vantman D, Ponce J, Escobar J, Lissi E. Total antioxidant capacity of human seminal plasma. Hum Reprod 1996; 11: 1655-60.
  31. Zini A, De Lamirande E, Gagnon C. Reactive oxygen species in semen of infertile patients: levels of superoxide dismutase - and catalase - like activities in seminal plasma and spermatozoa. Int J Androl 1993; 16: 183-8.
  32. Kobayashi T, Miyazaki T, Natori M, Nozawa S. Protective role of superoxide dismutase in human sperm motility: superoxide dismutase activity and lipid peroxide in human seminal plasma and spermatozoa. Hum Reprod 1991; 6: 987-91.
  33. Zini A, Schlegel P.N. Catalase mRNA expression in the male rat reproductive tract. J Androl 1996; 17: 473-80.
  34. Thiele J.J, Friesleben H.J, Fuchs J, Ochsendorf F.R. Ascorbic acid and urate in human seminal plasma: determination and interrelationships with chemiluminescence in washed semen. Hum Reprod 1995; 10: 110-5.
  35. Kalthur G, Adiga S.K, Upadhya D et al. Effect of cryopreservation on sperm DNA integrity in patients with teratospermia. Fertil Steril 2008; 89: 1723-7.
  36. Tauber P.F, Zaneveld L.J, Propping D, Schumacher G.F. Components of human split ejaculates. I. Spermatozoa, fructose, immunoglobulins, albumin, lactoferrin, transferrin and other plasma proteins. J Reprod Fertil 1975; 43: 249-67.
  37. Smith R, Vantman D, Ponce J et al. Total antioxidant capacity of human seminal plasma. Hum Reprod 1996; 11: 1655-60.
  38. Lewis S.E, Sterling E.S, Young I.S, Thompson W. Comparison of individual antioxidants of sperm and seminal plasma in fertile and infertile men. Fertil Steril 1997; 67: 142-7.
  39. Sanocka D, Miesel R, Jedrzejczak P, Kurpisz M.K. Oxidative stress and male infertility.J Androl 1996; 17: 449-54.
  40. Lewis S.E, Boyle P.M, Mc Kinney K.A, Young I.S, Thompson W. Total antioxidant capacity of seminal plasma is different in fertile and infertile men. Fertil Steril 1995; 64: 868-70.
  41. Appasamy M, Muttukrishna S, Pizzey A.R et al. Relationship between male reproductive hormones, sperm DNA damage and markers of oxidative stress in infertility. Reprod Biomed Online 2007; 14: 159-65.
  42. Verit F.F, Verit A, Kocyigit A et al. No increase in sperm DNA damage and seminal oxidative stress in patients with idiopathic infertility. Arch Gynecol Obstet 2006; 274: 339-44.
  43. Hampl J.S, Taylor C.A, Johnston C.S. Vitamin C deficiency and depletion in the United States: the Third National Health and Nutrition Examination Survey, 1988 to 1994. Am J Public Health 2004; 94: 870-5.
  44. Мухина Ю.Г., Ключников С.О., Нетребенко О.К., Щеплягина Л.А. Клиническое значение нарушений метаболизма цинка. 2011.
  45. Ефремов Е.А., Охоботов Д.А., Мельник Я.И. Применение препарата Селцинк Плюс в комбинированной терапии хронического простатита и доброкачественной гиперплазии предстательной железы. Эксперим. и клин. урология, 2014.
  46. Козаренко В.Г. Дефицит цинка у детей с задержкой роста и полового развития. Автореф. дис. … канд. мед. наук. Спб., 2008.
  47. Авцын А.П., Жаворонков А.А., Риш М.А. и др. Микроэлементозы человека: этиология, классификация, органопатология. М., 1991.
  48. Алексеенко В.А., Алещукин Л.В. и др. Цинк и кадмий в окружающей среде. М., 1992.
  49. Скальный А.В. Эколого - физиологическое обоснование эффективности использования макро - и микроэлементов при нарушениях гомеостаза у обследуемых из различных климатогеографических регионов. Дис. … д - ра мед. наук. М., 2000.
  50. Golubkina N.A., Alfthan G.V. The human selenium status in 27 regions of Russia. J Trace Elem Med Biol 1999; 13: 15-20.
  51. Коровина Н.А. Профилактика рахита у детей: применение кальция. Лечащий врач. 2004; 1: 56-8.
  52. Ruel M.T, Rivera J.A, Santizo M-C et al. Impact of Zinc Supplementation on Morbidity From Diarrhea and Respiratory Infections Among Rural Guatemalan Children. Pediatrics 1997; 99: 808-13.

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies